Works matching IS 22113428 AND DT 2023 AND VI 46 AND IP 5

Results: 23

Correction to: CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation.

Published in:

2023

By:

Frontiñán-Rubio, Javier;
Llanos-González, Emilio;
García-Carpintero, Sonia;
Peinado, Juan Ramón;
Ballesteros-Yáñez, Inmaculada;
Rayo, Margarita Villar;
de la Fuente, José;
Pérez-García, Víctor M.;
Perez-Romasanta, Luis A.;
Malumbres, Marcos;
Alcaín, Francisco J.;
Durán-Prado, Mario

Publication type:

Correction Notice

METTL3 suppresses pancreatic ductal adenocarcinoma progression through activating endogenous dsRNA-induced anti-tumor immunity.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1529, doi. 10.1007/s13402-023-00829-2

By:

Zhu, Lili;
Li, Botai;
Li, Rongkun;
Hu, Lipeng;
Zhang, Yanli;
Zhang, Zhigang;
Jiang, Shuheng;
Zhang, Xueli

Publication type:

Article

LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1509, doi. 10.1007/s13402-023-00826-5

By:

Pei, Lu;
Yan, Dong;
He, Qingqing;
Kong, Jianqiu;
Yang, Meihua;
Ruan, Honglian;
Lin, Qiongqiong;
Huang, Lifang;
Huang, Jian;
Lin, Tianxin;
Qin, Haide

Publication type:

Article

TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1493, doi. 10.1007/s13402-023-00825-6

By:

Zhong, Tian;
Zhang, Jing;
Liu, Xingren;
Li, Hongmin

Publication type:

Article

Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1473, doi. 10.1007/s13402-023-00824-7

By:

Zhang, Shan;
Yao, Hong-Fei;
Li, Hui;
Su, Tong;
Jiang, Shu-Heng;
Wang, Hao;
Zhang, Zhi-Gang;
Dong, Fang-Yuan;
Yang, Qin;
Yang, Xiao-Mei

Publication type:

Article

Competition between p53 and YY1 determines PHGDH expression and malignancy in bladder cancer.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1457, doi. 10.1007/s13402-023-00823-8

By:

Shi, Tiezhu;
Yuan, Zhihao;
He, Yanying;
Zhang, Dongliang;
Chen, Siteng;
Wang, Xiongjun;
Yao, Linli;
Shao, Jialiang;
Wang, Xiang

Publication type:

Article

Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/STAT3 pathway.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1445, doi. 10.1007/s13402-023-00822-9

By:

Ji, Yiyi;
Liu, Bo;
Chen, Lei;
Li, Ang;
Shen, Kai;
Su, Ruopeng;
Zhang, Weiwei;
Zhu, Yinjie;
Wang, Qi;
Xue, Wei

Publication type:

Article

MAOA suppresses the growth of gastric cancer by interacting with NDRG1 and regulating the Warburg effect through the PI3K/AKT/mTOR pathway.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1429, doi. 10.1007/s13402-023-00821-w

By:

Wang, Yang-Yang;
Zhou, Yao-Qi;
Xie, Jia-Xuan;
Zhang, Xiang;
Wang, Shu-Chang;
Li, Qing;
Hu, Li-Peng;
Jiang, Shu-Heng;
Yi, Shuang-Qin;
Xu, Jia;
Cao, Hui;
Zhao, En-Hao;
Li, Jun

Publication type:

Article

Single-cell RNA sequencing reveals the cellular and molecular characteristics of high-grade and metastatic bladder cancer.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1415, doi. 10.1007/s13402-023-00820-x

By:

Zheng, Yue;
Wang, Xin;
Yang, Xiaofeng;
Xing, Nianzeng

Publication type:

Article

RRM2 as a novel prognostic and therapeutic target of NF1-associated MPNST.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1399, doi. 10.1007/s13402-023-00819-4

By:

Chung, Man-Hon;
Aimaier, Rehanguli;
Yu, Qingxiong;
Li, Haibo;
Li, Yuehua;
Wei, Chengjiang;
Gu, Yihui;
Wang, Wei;
Guo, Zizhen;
Long, Manmei;
Li, Qingfeng;
Wang, Zhichao

Publication type:

Article

A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1381, doi. 10.1007/s13402-023-00818-5

By:

Li, Jingwei;
Lin, Jiewei;
Ji, Yuchen;
Wang, Xuelong;
Fu, Da;
Wang, Weishen;
Shen, Baiyong

Publication type:

Article

Non-canonical role for the ataxia-telangiectasia-Rad3 pathway in STAT3 activation in human multiple myeloma cells.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1369, doi. 10.1007/s13402-023-00817-6

By:

Li, Lin;
Hu, Xiaoyan;
Nkwocha, Jewel;
Sharma, Kanika;
Kmieciak, Maciej;
Mann, Hashim;
Zhou, Liang;
Grant, Steven

Publication type:

Article

Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1351, doi. 10.1007/s13402-023-00816-7

By:

Hu, Zhengyang;
Jin, Xing;
Hong, Weifeng;
Sui, Qihai;
Zhao, Mengnan;
Huang, Yiwei;
Li, Ming;
Wang, Qun;
Zhan, Cheng;
Chen, Zhencong

Publication type:

Article

The therapeutic potential of exosomes in lung cancer.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1181, doi. 10.1007/s13402-023-00815-8

By:

Liang, Hongyuan;
Zhang, Lingyun;
Zhao, Xiangxuan;
Rong, Jian

Publication type:

Article

Aberrant expression of circular RNA DHPR facilitates tumor growth and metastasis by regulating the RASGEF1B/RAS/MAPK axis in hepatocellular carcinoma.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1333, doi. 10.1007/s13402-023-00814-9

By:

Guo, Zeyi;
Xie, Qingyu;
Wu, Yanping;
Mo, Haiyu;
Zhang, Jiajun;
He, Guolin;
Li, Zhongzhe;
Gan, Luxiang;
Feng, Lei;
Li, Ting;
Wang, Yi;
Fu, Yu;
Cai, Lei;
Li, Shao;
Yu, Chao;
Gao, Yi;
Pan, Mingxin;
Fu, Shunjun

Publication type:

Article

PAQR5 inhibits the growth and metastasis of clear cell renal cell carcinoma by suppressing the JAK/STAT3 signaling pathway.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1317, doi. 10.1007/s13402-023-00813-w

By:

Wang, Lu;
Yue, Yangyang;
Zhang, Lu;
Jing, Minxuan;
Ma, Minghai;
Liu, Chao;
Li, Yan;
Xu, Shan;
Wang, Ke;
Wang, Xinyang;
Fan, Jinhai;
Zhang, Mengzhao

Publication type:

Article

Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1301, doi. 10.1007/s13402-023-00812-x

By:

Chen, Kun-Chi;
Hsiao, I-Hsin;
Huang, Yu-Nan;
Chou, Yu-Tung;
Lin, Yi-Chun;
Hsieh, Ju-Yi;
Chang, Yung-Lung;
Wu, Kang-Hsi;
Liu, Guang-Yaw;
Hung, Hui-Chih

Publication type:

Article

SYVN1 ubiquitinates FoxO1 to induce β-catenin nuclear translocation, PD-L1-mediated metastasis, and immune evasion of hepatocellular carcinoma.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1285, doi. 10.1007/s13402-023-00811-y

By:

Xie, Wei;
Shi, Lei;
Quan, Hu;
Xiao, Hua;
Chen, Jie;
Liu, Jia;
de Dieu Habimana, Jean;
Huang, Rongqi;
Luo, Jia;
Chen, Pan;
Li, Zhiyuan

Publication type:

Article

Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1159, doi. 10.1007/s13402-023-00810-z

By:

Patel, Gayatri;
Agnihotri, Tejas Girish;
Gitte, Manoj;
Shinde, Tanuja;
Gomte, Shyam Sudhakar;
Goswami, Roshan;
Jain, Aakanchha

Publication type:

Article

TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1269, doi. 10.1007/s13402-023-00809-6

By:

Jiang, Xinyu;
Du, Wenfei;
Yang, Chenglong;
Wang, Shuying;
Li, Yifei;
Shen, Xinzhuang;
Yang, Xiaowen;
Yao, Jie;
Du, Renle;
Zhang, Xiaoyuan;
Huang, Yongming;
Shen, Wenzhi

Publication type:

Article

Comprehensive analysis of clinical prognostic features and tumor microenvironment landscape of CD11b+CD64+ patients with acute myeloid leukemia.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1253, doi. 10.1007/s13402-023-00808-7

By:

Wang, Qian;
Zhang, Nan;
Liu, Li;
Ma, Linlu;
Tan, Yuxin;
Liu, Xiaoyan;
Wu, Jinxian;
Chen, Guopeng;
Li, Xinqi;
Liang, Yuxing;
Zhou, Fuling

Publication type:

Article

DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1235, doi. 10.1007/s13402-023-00807-8

By:

Feng, Tianyu;
Li, Siqi;
Zhao, Gang;
Li, Qin;
Yuan, Hang;
Zhang, Jie;
Gu, Rui;
Ou, Deqiong;
Guo, Yafei;
Kou, Qiming;
Wang, Qijing;
Li, Kai;
Lin, Ping

Publication type:

Article

MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer.

Published in:

Cellular Oncology (2211-3428), 2023, v. 46, n. 5, p. 1213, doi. 10.1007/s13402-023-00805-w

By:

Kuo, Sung-Hsin;
Wei, Ming-Feng;
Lee, Yi-Hsuan;
Lin, Jui-Chueh;
Yang, Wen-Chi;
Yang, Shi-Yi;
Huang, Chiun-Sheng

Publication type:

Article

Works matching IS 22113428 AND DT 2023 AND VI 46 AND IP 5

Correction to: CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation.

METTL3 suppresses pancreatic ductal adenocarcinoma progression through activating endogenous dsRNA-induced anti-tumor immunity.

LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder.

TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer.

Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer.

Competition between p53 and YY1 determines PHGDH expression and malignancy in bladder cancer.

Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/STAT3 pathway.

MAOA suppresses the growth of gastric cancer by interacting with NDRG1 and regulating the Warburg effect through the PI3K/AKT/mTOR pathway.

Single-cell RNA sequencing reveals the cellular and molecular characteristics of high-grade and metastatic bladder cancer.

RRM2 as a novel prognostic and therapeutic target of NF1-associated MPNST.

A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis.

Non-canonical role for the ataxia-telangiectasia-Rad3 pathway in STAT3 activation in human multiple myeloma cells.

Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma.

The therapeutic potential of exosomes in lung cancer.

Aberrant expression of circular RNA DHPR facilitates tumor growth and metastasis by regulating the RASGEF1B/RAS/MAPK axis in hepatocellular carcinoma.

PAQR5 inhibits the growth and metastasis of clear cell renal cell carcinoma by suppressing the JAK/STAT3 signaling pathway.

Targeting human mitochondrial NAD(P)<sup>+</sup>-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia.

SYVN1 ubiquitinates FoxO1 to induce β-catenin nuclear translocation, PD-L1-mediated metastasis, and immune evasion of hepatocellular carcinoma.

Exosomes: a potential diagnostic and treatment modality in the quest for counteracting cancer.

TBX21 attenuates colorectal cancer progression via an ARHGAP29/RSK/GSK3β dependent manner.

Comprehensive analysis of clinical prognostic features and tumor microenvironment landscape of CD11b<sup>+</sup>CD64<sup>+</sup> patients with acute myeloid leukemia.

DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis.

MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer.